Lion Point Capital, LP Lumos Pharma, Inc. Put Options Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LUMO
# of Institutions
21Shares Held
694KCall Options Held
0Put Options Held
0-
Jefferies Financial Group Inc. New York, NY121KShares$523,6250.0% of portfolio
-
Jefferies Group LLC New York, NY121KShares$523,6250.01% of portfolio
-
Black Rock Inc. New York, NY41.1KShares$178,3910.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX19.6KShares$85,2500.0% of portfolio
-
State Street Corp Boston, MA11.2KShares$48,7680.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...